Contact
Please use this form to send email to PR contact of this press release:
URGN CLASS ACTION: Invest in UroGen Pharma Ltd.? Contact BFA Law about the Pending Securities Fraud Class Action to Potentially Recover Losses (NASDAQ:URGN)
TO: